A carregar...
Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa
OBJECTIVES: The high cost of rifampicin‐resistant tuberculosis (RR‐TB) treatment hinders treatment access. South Africa has a high RR‐TB burden, and national policy outlines decentralisation to improve access and reduce costs. We analysed health system costs associated with RR‐TB treatment by drug r...
Na minha lista:
| Publicado no: | Trop Med Int Health |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864411/ https://ncbi.nlm.nih.gov/pubmed/25975868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tmi.12544 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|